Image de couverture de livre

Development of the treatment preference in myelodysplasia questionnaire for clinicians, carers, and patients

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Robert Morlock, Chun Fong, Francesco Castaldi, Taliesha Paine, Donna Collett, Anoop Enjeti
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	eJHaem
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma
par: Ke Xu, et autres
Publié: (2024)

Real‐world characteristics and outcomes of patients with multiple myeloma receiving second‐line treatment in England
par: Sally Moore, et autres
Publié: (2024)

Lisocabtagene maraleucel for treatment of relapsed and refractory primary mediastinal large B‐cell lymphoma in an adolescent patient
par: Dasom Lee, et autres
Publié: (2024)

IFN‐α treatment may enable discontinuation of TKIs in NK cell‐licensed patients with CML‐CP
par: Hiroshi Ureshino, et autres
Publié: (2024)

Medical history and lifestyle factors have limited impact on time‐to‐first‐treatment in patients with chronic lymphocytic leukemia
par: Ingrid Glimelius, et autres
Publié: (2024)

Successful treatment of low‐risk myelodysplastic syndrome‐related anemia in patients with chronic kidney disease with daprodustat: A report of two cases
par: Hiroyoshi Kunimoto, et autres
Publié: (2024)

Immediate improvement in patient care: Auditing adherence to the British Society for Haematology guidelines on screening and management of the long‐term consequences of multiple myeloma and treatment
par: Kerrie Sweeney, et autres
Publié: (2024)

Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients
par: Alfonso Piciocchi, et autres
Publié: (2024)

Successful treatment of acyclovir‐resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T‐cell prolymphocytic leukemia
par: Yuma Kawamura, et autres
Publié: (2024)

Primary Bone Marrow Classic Hodgkin Lymphoma With Haemophagocytic Lymphohistiocytosis
par: Chun‐Tsu Lee
Publié: (2025)

Changes in indicators of cerebral metabolic stress following treatment with voxelotor in children and adolescents with sickle cell anemia
par: Andrew M. Heitzer, et autres
Publié: (2024)

Metabolic pitfall of pseudoprogression after epcoritamab treatment
par: Osamu Imataki, et autres
Publié: (2024)

Real‐world practitioner perceptions of CARTITUDE‐4 results for patients with previously treated multiple myeloma
par: Alexandrina Balanean, et autres
Publié: (2024)

Red blood cell transfusion and the use of intravenous iron in iron‐deficient patients presenting to the emergency department
par: Kevin Thomas, et autres
Publié: (2024)

The use of Ambroxol for the treatment of Gaucher disease: A systematic review
par: Diego Agustín Abelleyra Lastoria, et autres
Publié: (2024)

Long‐term follow‐up of outcomes including progression‐free survival 2 in patients with transplant‐ineligible multiple myeloma in the real‐world practice: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) database
par: Rayan Kaedbey, et autres
Publié: (2024)

Rapid high‐dose cyclophosphamide as bridging treatment for advanced therapies in multiple myeloma
par: Marcus Marable, et autres
Publié: (2024)

Low‐dose decitabine plus venetoclax as post‐transplant maintenance for high‐risk myeloid malignancies
par: Katherine Parks, et autres
Publié: (2024)

Elevated levels of citrullinated fibrinogen in patients with cancer
par: Tom Arfman, et autres
Publié: (2024)

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study
par: Jieling Jiang, et autres
Publié: (2024)

Immune profiling of responses to influenza vaccination in patients with myeloproliferative neoplasms
par: Petra Bachanová, et autres
Publié: (2024)

Iatrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab—A case report
par: Erik Boberg, et autres
Publié: (2024)

Enteropathy‐associated T‐cell lymphoma: A population‐based cohort study on incidence, treatment, and outcome in the Netherlands
par: Frederik O. Meeuwes, et autres
Publié: (2024)

Effective treatment of refractory monoclonal gammopathy‐associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasone
par: Christian Sebastian Michel, et autres
Publié: (2024)

Antimicrobial Peptides Induce Cell Death in Marginal Zone Lymphoma Models Resistant to Targeted Therapies
par: Filippo Spriano, et autres
Publié: (2026)

Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients
par: Erica Franceschini, et autres
Publié: (2024)

Asteatotic eczema, a cutaneous manifestation of Hodgkin lymphoma in older patients
par: Ariane Le Clainche Compagnie, et autres
Publié: (2024)

Comment on “Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients”
par: Hinpetch Daungsupawong, et autres
Publié: (2024)

A decade of chronic lymphocytic leukaemia therapy in Germany: Real‐world treatment patterns and outcomes (2010–2022)
par: Hannes Wartmann, et autres
Publié: (2024)

Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab
par: Syed Naqvi, et autres
Publié: (2024)

Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia
par: Nilesh Kapoor, et autres
Publié: (2024)

Real‐world treatment of large B‐cell lymphoma with chimeric antigen receptor T‐cell therapy after loncastuximab tesirine
par: Mehdi Hamadani, et autres
Publié: (2024)

Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Acute Myeloid Leukaemia
par: Gabriel N. Mannis, et autres
Publié: (2025)

The evolving treatment landscape of multiple myeloma in Portugal: A nation‐wide retrospective cohort study of real‐world clinical practice
par: Rui Bergantim, et autres
Publié: (2024)

Sequential treatment with valemetostat and conventional anti‐cancer drugs for refractory aggressive adult T‐cell leukemia/lymphoma: A case report
par: Kosuke Obama, et autres
Publié: (2024)

Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy
par: Nicole Lamanna, et autres
Publié: (2024)

Fostamatinib for immune thrombocytopenic purpura in adult patients: A systematic review and meta‐analysis
par: Roger Kou, et autres
Publié: (2024)

Effective treatment of relapsed/refractory CD19‐positive B/T‐type mixed‐phenotype acute leukemia with blinatumomab: A case report
par: Masanori Aoki, et autres
Publié: (2024)

Successful treatment of refractory donor‐specific‐human leukocyte antigen‐antibody‐induced primary graft‐failure with daratumumab: A case report
par: Vadim Lesan, et autres
Publié: (2024)

Oral squamous cell carcinoma in a patient affected by chronic graft versus host disease
par: Sem Decani, et autres
Publié: (2024)